Entero Healthcare [ENTERO] vs Royal Sense [ROYAL] Detailed Stock Comparison

Entero Healthcare

NSE
Loading...

Royal Sense

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Entero Healthcare wins in 6 metrics, Royal Sense wins in 11 metrics, with 0 ties. Royal Sense appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricEntero HealthcareRoyal SenseBetter
P/E Ratio (TTM)48.2420.96Royal Sense
Price-to-Book Ratio2.864.44Entero Healthcare
Debt-to-Equity Ratio21.7611.74Royal Sense
PEG Ratio1.26N/AN/A
EV/EBITDA25.3412.97Royal Sense
Profit Margin (TTM)1.90%10.26%Royal Sense
Operating Margin (TTM)2.94%12.41%Royal Sense
EBITDA Margin (TTM)2.94%12.41%Royal Sense
Return on Equity5.36%27.55%Royal Sense
Return on Assets (TTM)3.51%19.68%Royal Sense
Free Cash Flow (TTM)$-881.80M$-4.08MRoyal Sense
1-Year Return-13.53%19.78%Royal Sense
Price-to-Sales Ratio (TTM)0.912.15Entero Healthcare
Enterprise Value$49.37B$1.15BEntero Healthcare
EV/Revenue Ratio0.911.87Entero Healthcare
Gross Profit Margin (TTM)9.94%15.60%Royal Sense
Revenue per Share (TTM)$1,242$124Entero Healthcare
Earnings per Share (Diluted)$23.51$11.83Entero Healthcare
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Entero Healthcare vs Royal Sense Stock Performance Analysis

Loading Price Chart...

Entero Healthcare
Royal Sense
Entero Healthcare Stock Overview | Royal Sense Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Entero Healthcare-0.59%3.19%-3.55%-5.33%0.08%-21.46%
Royal Sense-1.25%-5.81%-8.99%2.30%36.06%-19.97%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Entero Healthcare-13.53%-1.92%-1.92%-1.92%-1.92%-1.92%
Royal Sense19.78%119.70%119.70%119.70%119.70%119.70%

News Based Sentiment: Entero Healthcare vs Royal Sense

Entero Healthcare

News based Sentiment: MIXED

October presented a mixed bag for Entero Healthcare Solutions, with positive price movements and analyst upgrades offset by continued volatility, a 52-week low, and a recent divestiture. The company is clearly in a period of change, making this a significant month for investors to assess its future direction.

View Entero Healthcare News Sentiment Analysis

Royal Sense

News based Sentiment: MIXED

Royal Sense Ltd. has shown strong financial growth, with a significant increase in net profit and market capitalization. However, the recent stock price decline and changes in shareholding patterns introduce uncertainty and suggest a potential shift in investor sentiment, creating a mixed investment outlook.

View Royal Sense News Sentiment Analysis

Performance & Financial Health Analysis: Entero Healthcare vs Royal Sense

MetricENTEROROYAL
Market Information
Market Cap i₹49.35B₹1.38B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i197,9981,500
90 Day Avg. Volume i136,8744,883
Last Close₹1,127.50₹244.90
52 Week Range₹1,044.90 - ₹1,584.25₹175.00 - ₹316.05
% from 52W High-28.83%-22.51%
All-Time High₹1,584.25 (Nov 04, 2024)₹316.05 (Dec 30, 2024)
% from All-Time High-28.83%-22.51%
Growth Metrics
Quarterly Revenue Growth0.28%4.19%
Quarterly Earnings Growth0.38%3.97%
Financial Health
Profit Margin (TTM) i0.02%0.10%
Operating Margin (TTM) i0.03%0.12%
Return on Equity (TTM) i0.05%0.28%
Debt to Equity (MRQ) i21.7611.74
Cash & Liquidity
Book Value per Share (MRQ)₹396.70₹55.83
Cash per Share (MRQ)₹73.09₹22.64
Operating Cash Flow (TTM) i₹-1,784,990,000₹12.08M
Levered Free Cash Flow (TTM) i₹948.20M₹-32,759,124
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Entero Healthcare vs Royal Sense

MetricENTEROROYAL
Price Ratios
P/E Ratio (TTM) i48.2420.96
Forward P/E i22.17N/A
PEG Ratio i1.26N/A
Price to Sales (TTM) i0.912.15
Price to Book (MRQ) i2.864.44
Market Capitalization
Market Capitalization i₹49.35B₹1.38B
Enterprise Value i₹49.37B₹1.15B
Enterprise Value Metrics
Enterprise to Revenue i0.911.87
Enterprise to EBITDA i25.3412.97
Risk & Other Metrics
Beta iN/AN/A
Book Value per Share (MRQ) i₹396.70₹55.83

Financial Statements Comparison: Entero Healthcare vs Royal Sense

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ENTEROROYAL
Revenue/Sales i₹14.04B₹33.92M
Cost of Goods Sold i₹12.64B₹28.63M
Gross Profit i₹1.40B₹5.29M
Research & Development iN/AN/A
Operating Income (EBIT) i₹412.02M₹2.60M
EBITDA i₹558.96M₹2.69M
Pre-Tax Income i₹363.63M₹2.65M
Income Tax i₹61.31M₹690,000
Net Income (Profit) i₹302.32M₹1.96M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ENTEROROYAL
Cash & Equivalents i₹2.29B₹30.67M
Total Current Assets i₹20.76B₹223.51M
Total Current Liabilities i₹8.45B₹34.38M
Long-Term Debt i₹670.18MN/A
Total Shareholders Equity i₹17.70B₹205.89M
Retained Earnings i₹638.28MN/A
Property, Plant & Equipment i₹1.64BN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ENTEROROYAL
Operating Cash Flow iN/A₹50.91M
Capital Expenditures iN/A₹233,000
Free Cash Flow iN/A₹26.63M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricENTEROROYAL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i197,9981,500
Average Daily Volume (90 Day) i136,8744,883
Shares Outstanding i43.51M4.97M
Float Shares i11.24M1.50M
% Held by Insiders i0.63%0.68%
% Held by Institutions i0.20%0.00%

Dividend Analysis & Yield Comparison: Entero Healthcare vs Royal Sense

MetricENTEROROYAL
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A